These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 39053135)
1. P4HA3 promotes head and neck squamous cell carcinoma progression via the WNT/β-catenin signaling pathway. Wang Q; Meng D; Shen S; Cao Y; Zhang P; Liu Y; Du L; Li H; Shao C; Dong Q Pathol Res Pract; 2024 Aug; 260():155481. PubMed ID: 39053135 [TBL] [Abstract][Full Text] [Related]
2. ELOVL6 promotes the progression of head and neck squamous cell carcinoma via activating WNT/β-catenin pathway. Wang R; Liu X; Li X; Qian M; Yang X; Jiang Q; Wang Y; Liu H; Chen J; Wang X; Gong L Mol Carcinog; 2024 Jun; 63(6):1079-1091. PubMed ID: 38426809 [TBL] [Abstract][Full Text] [Related]
3. Upregulation of lncRNA LINC00473 promotes radioresistance of HNSCC cells through activating Wnt/β-catenin signaling pathway. Han PB; Ji XJ; Zhang M; Gao LY Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7305-7313. PubMed ID: 30468475 [TBL] [Abstract][Full Text] [Related]
4. FAM83A promotes proliferation and metastasis via Wnt/β-catenin signaling in head neck squamous cell carcinoma. Ji H; Song H; Wang Z; Jiao P; Xu J; Li X; Du H; Wu H; Zhong Y J Transl Med; 2021 Oct; 19(1):423. PubMed ID: 34641907 [TBL] [Abstract][Full Text] [Related]
5. HOXB5 acts as an oncogenic driver in head and neck squamous cell carcinoma via EGFR/Akt/Wnt/β-catenin signaling axis. Lee K; Chang JW; Oh C; Liu L; Jung SN; Won HR; Kim YI; Rha KS; Koo BS Eur J Surg Oncol; 2020 Jun; 46(6):1066-1073. PubMed ID: 31864826 [TBL] [Abstract][Full Text] [Related]
6. Prolyl 4-hydroxylase subunit alpha 3 presents a cancer promotive function in head and neck squamous cell carcinoma via regulating epithelial-mesenchymal transition. Wang T; Wang YX; Dong YQ; Yu YL; Ma K Arch Oral Biol; 2020 May; 113():104711. PubMed ID: 32220804 [TBL] [Abstract][Full Text] [Related]
7. CUL4B promotes aggressive phenotypes of HNSCC via the activation of the Wnt/β-catenin signaling pathway. Wang Y; Yue D Cancer Med; 2019 May; 8(5):2278-2287. PubMed ID: 30883036 [TBL] [Abstract][Full Text] [Related]
8. Cancer-associated fibroblasts secrete hypoxia-induced serglycin to promote head and neck squamous cell carcinoma tumor cell growth in vitro and in vivo by activating the Wnt/β-catenin pathway. Xie J; Qi X; Wang Y; Yin X; Xu W; Han S; Cai Y; Han W Cell Oncol (Dordr); 2021 Jun; 44(3):661-671. PubMed ID: 33651283 [TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma. Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980 [TBL] [Abstract][Full Text] [Related]
10. LncRNA LINC00460 promotes EMT in head and neck squamous cell carcinoma by facilitating peroxiredoxin-1 into the nucleus. Jiang Y; Cao W; Wu K; Qin X; Wang X; Li Y; Yu B; Zhang Z; Wang X; Yan M; Xu Q; Zhang J; Chen W J Exp Clin Cancer Res; 2019 Aug; 38(1):365. PubMed ID: 31429766 [TBL] [Abstract][Full Text] [Related]
11. Functional and genomic analyses reveal therapeutic potential of targeting β-catenin/CBP activity in head and neck cancer. Kartha VK; Alamoud KA; Sadykov K; Nguyen BC; Laroche F; Feng H; Lee J; Pai SI; Varelas X; Egloff AM; Snyder-Cappione JE; Belkina AC; Bais MV; Monti S; Kukuruzinska MA Genome Med; 2018 Jul; 10(1):54. PubMed ID: 30029671 [TBL] [Abstract][Full Text] [Related]
12. Increased FGL1 Expression Predicts Poor Prognosis and Promotes EMT in Head and Neck Squamous Cell Carcinoma. Pan Z; Hu W; Huang J; Zheng Z; Lin E; Wang P; Mao L Biochem Genet; 2024 Jun; 62(3):2066-2081. PubMed ID: 37843652 [TBL] [Abstract][Full Text] [Related]
13. Prolyl 4-hydroxylase subunit alpha 3 facilitates human colon cancer growth and metastasis through the TGF-β/Smad signaling pathway. Zhou H; Zou J; Shao C; Zhou A; Yu J; Chen S; Xu C Pathol Res Pract; 2022 Feb; 230():153749. PubMed ID: 34959098 [TBL] [Abstract][Full Text] [Related]
14. P4HA2 contributes to head and neck squamous cell carcinoma progression and EMT through PI3K/AKT signaling pathway. Wu YL; Liu W; Zhao T; Jin J Med Oncol; 2024 May; 41(6):163. PubMed ID: 38777998 [TBL] [Abstract][Full Text] [Related]
15. G-Protein-Coupled Receptor Kinase-Interacting Protein 1 (GIT1) Promotes Head and Neck Squamous Cell Carcinoma Metastases via Activating the PI3K/AKT/mTOR Signal Pathway. Xu R; Xu R; Wang Y; Wang W; Jiang L; Gong S Comput Math Methods Med; 2022; 2022():6881932. PubMed ID: 35116073 [TBL] [Abstract][Full Text] [Related]
16. Wnt/β-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4. Lee SH; Koo BS; Kim JM; Huang S; Rho YS; Bae WJ; Kang HJ; Kim YS; Moon JH; Lim YC J Pathol; 2014 Sep; 234(1):99-107. PubMed ID: 24871033 [TBL] [Abstract][Full Text] [Related]
17. RELA promotes the progression of oral squamous cell carcinoma via TFAP2A-Wnt/β-catenin signaling. Yang K; Zhao J; Liu S; Man S Mol Carcinog; 2023 May; 62(5):641-651. PubMed ID: 36789977 [TBL] [Abstract][Full Text] [Related]
18. KDM5B promotes metastasis and epithelial-mesenchymal transition via Wnt/β-catenin pathway in squamous cell carcinoma of the head and neck. Yuan W; Hu J; Wang M; Li G; Lu S; Qiu Y; Liu C; Liu Y Mol Carcinog; 2024 May; 63(5):885-896. PubMed ID: 38353298 [TBL] [Abstract][Full Text] [Related]
19. Kinesin Family Member C1 Overexpression Exerts Tumor-Promoting Properties in Head and Neck Squamous Cell Carcinoma via the Rac1/Wnt/β-catenin Pathway. Yu BY; Shi LG; Jiang C; Wang GK; Liu J; Wu TY Lab Invest; 2023 Jul; 103(7):100134. PubMed ID: 36990154 [TBL] [Abstract][Full Text] [Related]
20. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner. Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]